Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05681156 · ClinicalTrials.gov registry record
Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol
A clinical trial, sponsored by Meridian Bioscience.
- Completed
- Registry status
- 199
- Enrollment target
NCT05681156 is a clinical trial that has completed, run by Meridian Bioscience. The registered enrollment target is 199 participants.
The verdict
NCT05681156 has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
Beta trial to evaluate the preliminary clinical performance of the Curian S. pneumo/Legionella assay for its use in the qualitative detection of Streptococcus pneumoniae and/or Legionella pneumophila serogroup 1 antigens in human urine specimens.
Interventions
- OTHER N/A- There is no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-09-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05681156
The ClinicalTrials.gov registry entry for NCT05681156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N/A- There is no intervention. is the first listed.
NCT05681156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05681156 about?
NCT05681156 is a clinical study titled "Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol". Beta trial to evaluate the preliminary clinical performance of the Curian S. pneumo/Legionella assay for its use in the qualitative detection of Streptococcus pneumoniae and/or Legionella pneumophila serogroup 1 antigens in human urine specimens.
What is the current status of trial NCT05681156?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2023-02-01. Estimated completion is 2023-09-08.
What interventions are being tested in trial NCT05681156?
The interventions under investigation include: N/A- There is no intervention. (OTHER).
Who is sponsoring clinical trial NCT05681156?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.